Equities

Pharma-Bio Serv Inc

PBSV:QBB

Pharma-Bio Serv Inc

Actions
  • Price (USD)0.5299
  • Today's Change0.030 / 5.98%
  • Shares traded4.60k
  • 1 Year change-37.66%
  • Beta0.5777
Data delayed at least 15 minutes, as of Nov 25 2024 20:22 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast in USD

The one analyst offering a 12 month price target expects Pharma-Bio Serv Inc share price to rise to 1.65 in the next year from the last price of 0.5299.
High211.4%1.65
Med211.4%1.65
Low211.4%1.65

Earnings history & estimates in USD

On Sep 16, 2024, Pharma-Bio Serv Inc reported 3rd quarter 2024 losses of -0.014 per share. This result was in line with the expectation of the one analyst following the company and under-performed last year's 3rd quarter results by -0.034.
The next earnings announcement is expected on Jan 29, 2025.
Average growth rate-15.19%
Pharma-Bio Serv Inc reported annual 2023 earnings of 0.057 per share on Jan 29, 2024.
Average growth rate+7.11%
More ▼

Revenue history & estimates in USD

Pharma-Bio Serv, Inc. had 3rd quarter 2024 revenues of 2.42m. This missed the 3.50m estimate of the one analyst following the company. This was 42.94% below the prior year's 3rd quarter results.
Average growth rate-13.41%
Pharma-Bio Serv, Inc. had revenues for the full year 2023 of 16.98m. This was 12.49% below the prior year's results.
Average growth rate+6.28%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.